After trial data for a new medicine proved inconclusive, Sarepta Therapeutics joined with the parents of sick boys to persuade officials it helped.

Topics:  sarepta therapeutics   
  • U.S. FDA panel backs gene therapy for rare form of blindness
    Oct 12 (Reuters) - Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration ... which can range from $300,000 a year to $600,000 a year or more.
    10/12/2017 - 8:56 am | View Link
  • To appease a patient lobby, did the FDA approve a $300,000 drug that doesn't work?
    A couple of weeks ago, the big insurance company Anthem decided that it wouldn’t pay for Exondys 51, a drug that already had been approved by the Food and ... The drug costs $300,000 a year, and the evidence that it works is almost laughably thin.
    10/28/2016 - 9:06 am | View Link
  • Germany's Bayer wins FDA approval for hemophilia A therapy
    The U.S. Food and Drug Administration approved Bayer AG's therapy for the most common ... require frequent injections of blood clotting proteins that can cost up to $300,000 a year for a single patient. A Bayer spokeswoman said the company could not ...
    03/17/2016 - 9:04 pm | View Link
  • More
  • Main Page
    November 5, 2017. While the new tax reform legislation that is working it's way through Congress and the Senate has a few good points (less tax catagories, larger ...
    01/12/2018 - 11:47 am | View Website
  • SRPT Stock Price
    Sarepta Therapeutics Inc. stock price, stock quotes and financial overviews from MarketWatch.
    01/10/2018 - 7:10 am | View Website
  • The new price of hope
    The families of thousands of children who want Spinraza, a recently approved drug for spinal muscular atrophy, have faced hurdles ranging from slow ramp-ups at ...
    12/16/2017 - 7:21 pm | View Website
  • 'Ethical bordellos:' Op-eds don't always disclose Big ...
    Drug companies have been promoting their views on the nation’s op-ed pages via commentary writers who come across as neutral-sounding experts, and editors
    10/9/2017 - 8:41 am | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News